Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer (Q44961520)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer (English)

1 reference

Europe PubMed Central

7 December 2017

liver metastasis

1 reference

based on heuristic

inferred from title

author name string

Ying Wu

1

1 reference

Europe PubMed Central

7 December 2017

Sohsuke Yamada

2

1 reference

Europe PubMed Central

7 December 2017

Hiroto Izumi

3

1 reference

Europe PubMed Central

7 December 2017

Zhi Li

4

1 reference

Europe PubMed Central

7 December 2017

Shohei Shimajiri

5

1 reference

Europe PubMed Central

7 December 2017

Ke-Yong Wang

6

1 reference

Europe PubMed Central

7 December 2017

Yun-Peng Liu

7

1 reference

Europe PubMed Central

7 December 2017

Kimitoshi Kohno

8

1 reference

Europe PubMed Central

7 December 2017

Yasuyuki Sasaguri

9

1 reference

Europe PubMed Central

7 December 2017

publication date

3 January 2012

1 reference

Europe PubMed Central

7 December 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

7 December 2017

105

1 reference

Europe PubMed Central

7 December 2017

7

1 reference

Europe PubMed Central

7 December 2017

724-730

1 reference

Europe PubMed Central

7 December 2017

Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

The pleiotropic functions of the Y-box-binding protein, YB-1.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Metastasis: from dissemination to organ-specific colonization

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Molecular basis of metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

YB-1 bridges neural stem cells and brain tumor-initiating cells via its roles in differentiation and cell growth

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Biomolecular markers in cancer of the tongue

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Prognostic association of YB-1 expression in breast cancers: a matter of antibody.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23030

21 January 2018

Identifiers

10.1002/JSO.23030

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44961520&oldid=2059745895"